Docket

37478

Apotex Inc. v. AstraZeneca Canada Inc., et al.

(Federal) (Civil) (By Leave)

(Sealing order)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2017-06-06 Close file on Leave
2017-06-02 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2017-06-02 Judgment on leave sent to the parties
2017-06-01 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-201-15, 2017 FCA 9, dated January 12, 2017, is dismissed with costs.
Dismissed, with costs
2017-05-01 All materials on application for leave submitted to the Judges, for consideration by the Court
2017-04-24 Applicant's reply to respondent's argument, (Book Form), Completed on: 2017-04-24 Apotex Inc.
2017-04-13 Certificate (on limitations to public access) AstraZeneca Canada Inc.
2017-04-13 Notice of name AstraZeneca Canada Inc.
2017-04-13 Respondent's response on the application for leave to appeal, (Book Form), (2 volumes), Completed on: 2017-04-13 AstraZeneca Canada Inc.
2017-03-14 Letter acknowledging receipt of a complete application for leave to appeal, File opened on 2017-03-14
2017-03-13 Certificate (on limitations to public access), 23B Apotex Inc.
2017-03-13 Certificate (on limitations to public access), 23A Apotex Inc.
2017-03-13 Notice of name Apotex Inc.
2017-03-13 Application for leave to appeal, (Book Form), (2 volumes), Tab 8 is sealed, Completed on: 2017-03-13 Apotex Inc.